日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The novel risk score model for predicting the poor anticoagulation control in patients with atrial fibrillation taking warfarin

一种用于预测服用华法林治疗的房颤患者抗凝控制不良的新型风险评分模型

期刊:Asian Biomedicine
影响因子:0.9
doi:10.2478/abm-2025-0013
Methavigul, Komsing; Krittayaphong, Rungroj
发表日期：2025
文献求助 收藏

2025 Thai guideline for the diagnosis and management of atrial fibrillation

2025年泰国房颤诊断和治疗指南

期刊:Asian Biomedicine
影响因子:0.9
doi:10.2478/abm-2025-0028
Ngarmukos, Tachapong; Methavigul, Komsing; Rungpradubvong, Voravut; Apiyasawat, Sirin; Wongcharoen, Wanwarang; Pumprueg, Satchana; Boonyapisit, Warangkana; Suwannagool, Arisara; Chantrarat, Thoranis; Makarawate, Pattarapong; Wisaratapong, Treechada; Chintanavilas, Kumpol; Jiampo, Panyapat; Krittayaphong, Rungroj
发表日期：2025
文献求助 收藏

The COOL-AF Phase 2 Registry: COhort of Antithrombotic Use and Clinical Outcomes in Atrial Fibrillation Patients

COOL-AF 第二阶段注册研究：房颤患者抗血栓治疗及临床结局队列研究

期刊:JACC Asia
影响因子:
doi:10.1016/j.jacasi.2024.10.027
Krittayaphong, Rungroj; Winijkul, Arjbordin; Rungpradubvong, Voravut; Apiyasawat, Sirin; Phrommintikul, Arintaya; Chantrarat, Thoranis; Methavigul, Komsing; Chichareon, Ply; Makarawate, Pattarapong; Wongtheptien, Wattana; Kaolawanich, Yodying; Lip, Gregory Y H
心血管
发表日期：2025
文献求助 收藏

Incidence Rate and Predictors of Intracranial Hemorrhage in Patients With Atrial Fibrillation: A Report From the Nationwide COOL-AF Registry

房颤患者颅内出血的发生率和预测因素：来自全国 COOL-AF 注册研究的报告

期刊:Clinical Cardiology
影响因子:2.3
doi:10.1002/clc.70040
Krittayaphong, Rungroj; Ratanasumawong, Kasem; Methavigul, Komsing; Wongvipaporn, Chaiyasith; Lip, Gregory Y H
发表日期：2024
文献求助 收藏

Predictive model for left main coronary artery or triple vessel disease in patients with chronic coronary syndromes

慢性冠状动脉综合征患者左主干冠状动脉或三支血管病变的预测模型

期刊:Asian Biomedicine
影响因子:0.9
doi:10.2478/abm-2024-0024
Nuchanat, Piyanop; Methavigul, Komsing
发表日期：2024
文献求助 收藏

Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry

血压达标和治疗范围内时间延长对遵循房颤改善治疗路径的房颤患者临床结局的影响：来自 COOL-AF 注册研究的报告

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.122.028463
Krittayaphong, Rungroj; Winijkul, Arjbordin; Methavigul, Komsing; Lip, Gregory Y H
发表日期：2023
文献求助 收藏

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score

基于SAMe-TT(2)R(2)评分，比较华法林和非维生素K拮抗剂口服抗凝剂治疗房颤患者的疗效和安全性结果

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-023-03053-w
Methavigul, Komsing; Yindeengam, Ahthit; Krittayaphong, Rungroj
发表日期：2023
文献求助 收藏

Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHA(2)DS(2)-VASc score

基于CHA₂DS₂-VASc评分的亚洲房颤患者口服抗凝剂的净临床获益

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-023-03643-8
Methavigul, Komsing; Chichareon, Ply; Yindeengam, Ahthit; Krittayaphong, Rungroj
发表日期：2023
文献求助 收藏

Revised HAS-BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants

修订后的HAS-BLED评分用于预测服用口服抗凝剂的房颤患者的出血风险

期刊:Journal of Arrhythmia
影响因子:1.7
doi:10.1002/joa3.12709
Methavigul, Komsing
发表日期：2022
文献求助 收藏

Safety and efficacy of non-vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation

在泰国房颤患者中，非维生素K拮抗剂口服抗凝剂与控制良好的华法林相比的安全性和有效性

期刊:Asian Biomedicine
影响因子:0.9
doi:10.2478/abm-2022-0016
Yamkasikorn, Janekij; Methavigul, Komsing
发表日期：2022
文献求助 收藏